Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of mcFA on epigentic changes in A375 melanoma. [ChIP-seq]

ABSTRACT: Effects of mcFA on epigentic changes in A375 melanoma. [ChIP-seq]

PROVIDER: PRJNA839779 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19327280_1.fastq.gz	Fastqsanger.gz
	SRR19327280_2.fastq.gz	Fastqsanger.gz
	SRR19327281_1.fastq.gz	Fastqsanger.gz
	SRR19327281_2.fastq.gz	Fastqsanger.gz
	SRR19327282_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Effects of mcFA on epigentic changes in A375 melanoma [ATAC-seq]

Project description:Effects of mcFA on epigentic changes in A375 melanoma [ATAC-seq]

| PRJNA839774 | ENA

Effects of mcFA on epigentic changes in A375 melanoma. [ChIP-seq]

Project description:To study the epigenome profile of melanoma cells upon mcFAs administration, we stimulated A375 cells using octanoate for 48-hrs followed by H3K27ac ChIP-seq analysis with 2 biological replicates.

2024-06-01 | GSE203411 | GEO

Effects of mcFA on epigentic changes in A375 melanoma [ATAC-seq]

Project description:To study the epigenome profile of melanoma cells upon mcFAs administration, we stimulated A375 cells using octanoate for 48-hrs followed by ATAC-seq analysis with 2 biological replicates.

2024-06-01 | GSE203407 | GEO

Expression data from A375 melanoma parental and persister cells

Project description:Identify transcriptionnally and translationally regulated mRNA in melanoma parental and persister cells In this dataset, we include expression data of A375 melanoma drug-naïve parental cells and A375 melanoma persister cells that survived from BRAF and MEK inhibition. The expression data are studied in both total RNA and polysome-bounded RNA.

2019-09-20 | GSE137724 | GEO

A375 melanoma cells treated with leflunomide 25uM

Project description:Human A375 melanoma cells were treated with leflunomide 25uM for 3 days, then RNA harvested 6 arrays

2011-03-30 | E-GEOD-24526 | biostudies-arrayexpress

A375 melanoma cells treated with leflunomide 25uM

Project description:Human A375 melanoma cells were treated with leflunomide 25uM for 3 days, then RNA harvested

2011-03-30 | GSE24526 | GEO

NFATC2 knock-down on melanoma cell line A375

Project description:RNA-seq on NFATC2 knock-down (siRNA) on melanoma cell line A375

2017-09-29 | GSE99466 | GEO

Gene expression profiling of isogenic malignant melanoma A375-BRAFV600E/NRASQ61 and A375-BRAFV600E/NRASQ61K cell lines

Project description:BRAF-inhibitor (BRAFi)-resistance compromises long term survivorship of malignant melanoma patients, and mutant NRAS is a major mediator of BRAFi-resistance. We have employed NanoString nCounterTM transcriptomic analysis of isogenic human malignant melanoma cells that differ only by NRAS mutational status (BRAFi-sensitive A375-BRAFV600E/NRASQ61 versus BRAFi-resistant A375-BRAFV600E/NRASQ61K), identifying modulation of specific gene expression networks as a function of NRASQ61K-status.

2021-09-23 | GSE184633 | GEO

Analysis of gene expression profiles of human melanoma A375 cells with or without CD10 overexpression

Project description:Analysis of effect of CD10 in melanoma at gene expression level. The hypothesis tested in the present study was that CD10 promotes melanoma tumor progression. Results provide important information of the significant gene expression change between CD10-transfected and mock-transfected A375 cells, such as significantly increased genes included those related to anti-apoptosis, angiogenesis and cell proliferation. Total RNA obtained from CD10-transfected A375 melanoma cells was that from compared to mock-transfected A375 cells.

2014-10-18 | E-GEOD-62464 | biostudies-arrayexpress

A375 melanoma parental and persister cells

Project description:A375 melanoma parental and persister cells

| PRJNA566394 | ENA